The first-quarter earnings season for the drug and biotech sector will be in full swing this week, with many large drugmakers like Pfizer PFE, Eli Lilly LLY, Amgen AMGN, Biogen BIIB, and Regeneron Pharmaceuticals REGN, among others, due to announce results. Johnson & Johnson and Merck have already reported results,...
